amr industry alliance
The AMR Industry Alliance is one of the largest private sector coalitions set up to provide sustainable solutions to curb antimicrobial resistance, with over 100 biotech, diagnostics, generics and research-based pharmaceutical companies and associations joining forces.read more
We are uniting efforts to reduce the development of antimicrobial resistance, invest in R&D to meet public health needs and improve access to antibiotics, vaccines and diagnostics.
Despite the ongoing challenges presented by the pandemic, the AMR Industry Alliance’s 2021 Progress Report captures efforts made by the life sciences industry to fight AMR across several domains: research and science, access, appropriate use, and manufacturing. The third iteration of this biannual report captures progress made by Alliance members between July 2019 and March 2021. Find out more below.
Our case studies provide snap-shots from across the life-sciences industry, share information on the tangible steps we are taking to invest in new research to develop new antibiotics and vaccines, prevent infection ,and improve appropriate use of antibiotics.
amr in numbers
Life-sciences at the forefront of the battle against AMR
Development of National Action Plans
from the blog
Sepsis is a devastating condition resulting from a dysregulated immune system response to infection, which can lead to organ failure and death. Each year, sepsis affects close to 50 million people globally, of whom more than 40% are children under age 5 particularly in low- and middle-income countri...Read more view all